New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1715-0.0032 (-1.83%)
At close: 04:00PM EST
0.1797 +0.01 (+4.78%)
Pre-market: 04:59AM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.1747
Open0.1750
Bid0.1750 x 1100
Ask0.0000 x 900
Day's range0.1715 - 0.1880
52-week range0.1000 - 0.6240
Volume1,950,597
Avg. volume4,133,450
Market cap21.486M
Beta (5Y monthly)2.03
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer

    Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the field of complement (C5)NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LBT4) systems are implicated, today announced the appointment of Rachelle